BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer ...
FOXBusiness
A Phase I/II safety and tolerability study in 18 male patients with non-metastatic as well as hormone-insensitive prostate cancer has begun enrolment in the ...
Readmore...
[Source : Google News]
Tags:
0 Comments:
Post a Comment